Back to top

Image: Bigstock

XOMA Catches Eye: Stock Jumps 7.9%

Read MoreHide Full Article

XOMA Corporation (XOMA - Free Report) was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 39.1% in the past one-month time frame.

The company has seen one positive estimate revision in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for XOMA. So, make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

XOMA currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

A better-ranked stock in the Medical - Biomedical and Genetics industry is Cara Therapeutics, Inc. (CARA - Free Report) , which currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Biggest Tech Breakthrough in a Generation

Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.

A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.

See 8 breakthrough stocks now>>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


XOMA Corporation (XOMA) - free report >>

Cara Therapeutics, Inc. (CARA) - free report >>

Published in